射频消融治疗植入型心律转复除颤器术后电风暴疗效分析

赵谊昶, 刘金秋, 尹晓盟, 等. 射频消融治疗植入型心律转复除颤器术后电风暴疗效分析[J]. 临床心血管病杂志, 2021, 37(5): 473-478. doi: 10.13201/j.issn.1001-1439.2021.05.016
引用本文: 赵谊昶, 刘金秋, 尹晓盟, 等. 射频消融治疗植入型心律转复除颤器术后电风暴疗效分析[J]. 临床心血管病杂志, 2021, 37(5): 473-478. doi: 10.13201/j.issn.1001-1439.2021.05.016
ZHAO Yichang, LIU Jinqiu, YIN Xiaomeng, et al. Analysis of the effectiveness of radiofrequency ablation for electrical storm in patients with implantable cardioverter defibrillator[J]. J Clin Cardiol, 2021, 37(5): 473-478. doi: 10.13201/j.issn.1001-1439.2021.05.016
Citation: ZHAO Yichang, LIU Jinqiu, YIN Xiaomeng, et al. Analysis of the effectiveness of radiofrequency ablation for electrical storm in patients with implantable cardioverter defibrillator[J]. J Clin Cardiol, 2021, 37(5): 473-478. doi: 10.13201/j.issn.1001-1439.2021.05.016

射频消融治疗植入型心律转复除颤器术后电风暴疗效分析

  • 基金项目:

    国家自然科学基金(No:81700301)

    辽宁省教育厅科学研究经费项目(No:LZ2020058)

详细信息
    通讯作者: 陈菲菲,E-mail:sdaqchenfei@126.com
  • 中图分类号: R541.7

Analysis of the effectiveness of radiofrequency ablation for electrical storm in patients with implantable cardioverter defibrillator

More Information
  • 目的:探讨射频消融治疗植入型心律转复除颤器(ICD)患者术后电风暴的有效性。方法:回顾性纳入2010年1月1日—2019年12月31日就诊于大连医科大学附属第一医院行ICD或心脏再同步化治疗-除颤器(CRT-D)术后电风暴行射频消融治疗的患者。收集研究对象的年龄、性别、基础心脏病、心脏超声指标和B型利钠肽(BNP)等临床资料。出院后定期随访,随访一级终点为电风暴复发,二级终点为心脏性猝死和全因死亡。K-M曲线评估射频消融术后电风暴复发情况;Cox回归计算射频消融术后电风暴复发相关危险因素。结果:本研究共纳入13例患者(男11例,女2例),年龄(60.53±10.63)岁。13例患者共进行19次标测与消融,单纯行心内膜标测患者11例,心内膜结合心外膜标测患者2例。术中消融所有室性心动过速者共11例,消融临床室性心动过速但能诱发非持续性室性心动过速者2例,术后仍能诱发临床室性心动过速1例,消融即刻完全成功率为84.62%,部分成功率为15.38%,失败率为7.69%。13例患者消融后平均随访(30.29±19.07)个月,末次导管消融后远期完全成功率、部分成功率及失败率分别为38.46%(5/13)、15.38%(2/13)及46.15%(6/13)。随访至2020年7月31日,有2例患者因心室颤动电风暴死亡,基础病因分别为缺血性心肌病和扩张型心肌病。亚组比较扩张型心肌病组和非扩张型心肌病组,两组在消融成功率上无显著差异(P=0.959)。Cox回归发现年龄、BNP、左室射血分数、左室舒张末期内径、右室舒张末期内径、心功能分级均与射频消融术后电风暴复发无关。结论:射频消融能够显著减少ICD术后电风暴发生。
  • 加载中
  • [1]

    Deneke T,Shin DI,Lawo T,et al.Catheter ablation of electrical storm in a collaborative hospital network[J].Am J Cardiol,2011,108(2):233-239.

    [2]

    Al-Khatib SM,Stevenson WG,Ackerman MJ,et al.2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death:Executive Summary:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society[J].J Am Coll Cardiol,2018,72(14):1677-1749.

    [3]

    Al-Khatib SM,Fonarow GC,Joglar JA,et al.Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy:A Meta-analysis[J].JAMA Cardiol,2017,2(6):685-688.

    [4]

    Vergara P,Tung R,Vaseghi M,et al.Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival[J].Heart Rhythm,2018,15(1):48-55.

    [5]

    Streitner F,Kuschyk J,Dietrich C,et al.Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention[J].Clin Cardiol,2011,34(10):604-609.

    [6]

    Tsuji Y,Hojo M,Voigt N,et al.Ca(2+)-related signaling and protein phosphorylation abnormalities play central roles in a new experimental model of electrical storm[J].Circulation,2011,123(20):2192-2203.

    [7]

    Santangeli P,Muser D,Maeda S,et al.Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators:A systematic review and meta-analysis of randomized controlled trials[J].Heart Rhythm,2016,13(7):1552-1559.

    [8]

    Sapp JL,Wells GA,Parkash R,et al.Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs[J].N Engl J Med,2016,375(2):111-121.

    [9]

    Nayyar S,Ganesan AN,Brooks AG,et al.Venturing into ventricular arrhythmia storm:a systematic review and meta-analysis[J].Eur Heart J,2013,34(8):560-571.

    [10]

    Frankel DS,Mountantonakis SE,Robinson MR,et al.Ventricular tachycardia ablation remains treatment of last resort in structural heart disease:argument for earlier intervention[J].J Cardiovasc Electrophysiol,2011,22(10):1123-1128.

    [11]

    何嘉琳,李维杰,黄建楷,等.联合埋藏式心律转复除颤仪及射频消融治疗室性心律失常有效性的荟萃分析[J].临床心血管病杂志,2019,35(10):928-933.

    [12]

    Pappone C,Brugada J,Vicedomini G,et al.Electrical substrate elimination in 135consecutive patients with Brugada Syndrome[J].Circ Arrhythm Electrophysiol,2017,10(5):e005053-e005062.

    [13]

    Sen-Chowdhry S,McKenna WJ.Sudden death from genetic and acquired cardiomyopathies[J].Circulation,2012,125(12):1563-1576.

    [14]

    Schleberger R,Jularic M,Salzbrunn T,et al.Outcome of catheter ablation of non-reentrant ventricular arrhythmias in patients with and without structural heart disease[J].Eur J Med Res,2020,25(1):4-16.

    [15]

    Muser D,Liang JJ,Pathak RK,et al.Long-term outcomes of catheter ablation of electrical storm in nonischemic dilated cardiomyopathy compared with ischemic cardiomyopathy[J].JACC Clin Electrophysiol,2017,3(7):767-778.

  • 加载中
计量
  • 文章访问数:  558
  • PDF下载数:  286
  • 施引文献:  0
出版历程
收稿日期:  2020-11-19

目录